TPCN2 and cancer: These negative effects on patient prognosis are most likely due to the central role of TPC2 in regulating cancer cell proliferation and metastasis and highlight that inhibiting TPC2 activity is likely to be an anti-cancer therapeutic strategy for a range of cancer types.